Valerie Daggett

Valerie Daggett

Founder and CEO at AltPep
Seattle, Washington, United States

Valerie Daggett is the Founder and CEO of AltPep Corporation and a Professor at the University of Washington. She founded AltPep Corporation, which is still running.

Recent coverage

Front-page news, podcasts and videos about Valerie

See all 4

AltPep Raises $52.9M to Advance Early Detection and Treatments for Alzheimer’s and Parkinson’s Diseases

AltPep, a University of Washington spinout developing tests and treatments for Alzheimer’s and Parkinson’s, raised $52.9 million in Series B funding to advance clinical trials and regulatory approval for its early detection blood test. The company targets toxic oligomers linked to Alzheimer’s and a related protein in Parkinson’s, aiming to enable early screening and preventive treatment.

UW spinout AltPep raises $44.4M as its Alzheimer’s blood test earns FDA breakthrough designation

University of Washington spinout AltPep raised $44.4 million and is developing experimental blood tests to detect Alzheimer’s and Parkinson’s diseases early, plus treatments; its Alzheimer’s test received FDA breakthrough device designation. The three-year-old Seattle startup has 25 employees, raised $23.1M in a 2021 Series A, is hiring, and is pursuing partnerships and clinical-ready development.

Organizations

  • AltPep logo
    AltPep Executive Officer, Director, Promoter 2019–present, Founder and CEO 2019–present · current
  • University of Washington logo
    University of Washington Professor 1993–present · current

Education

  • Stanford University Structural Biology · 1990–1993
  • University of California, San Francisco Doctor of Philosophy (Ph.D.), Pharmaceutical Chemistry · 1985–1990
  • Reed College Bachelor’s Degree, Chemistry · 1979–1983

Online